AbelaPharm Swiss has successfully signed a purchase agreement, acquiring Alvogen’s factory in Serbia. Alvogen is a global pharmaceutical company specialized in the development and production of medicines, biosimilars and OTC goods. Due to Alvogen’s extensive as well...
We are pleased to announce that AbelaPharm Swiss producer, one of the leaders in the field of probiotic production in the Balkans, has officially acquired the production facility from German pharmaceutical company STADA in a nearby surrounding of Belgrade. This is the...
Vienna, Expert meeting 12th – 15th of October 2017 AbelaPharm held an expert meeting in Vienna, hosting over 50 medical practitioners from all over Serbia. The event had medical professionals speak on a number of topics – one of which, was the importance...
AbelaPharm took part in the 11th regional Pediatric Gastroenterology and Nutrition event hosted at the Sava Center, Belgrade. The main theme of the event revolved around Pediatric Gastroenterology and irritable bowel syndrome (IBS) faced by children. The medical...
Keynote speakers present: Dr. Valentina Marinković, professor, PhD (Serbia) Dr. Jun Ni, professor, PhD (USA) Dr. Numar Durakbasa, professor, PhD (Austria) Dr. Guenter Arndt, professor, PhD (Australia) AbelaPharm sponsored one of the most important seminars in Serbia...
The Swiss pharmaceutical company sponsored the 12th International conference on Quality UASQ ICQ which was organized by the United Association of Serbia for quality. The event was held at the University of Belgrade, in the faculty of engineering on, the 22nd of June...
